Atrion Reports Fourth Quarter and Full Year 2022 Results
Atrion Corporation (NASDAQ: ATRI) reported strong fourth-quarter and full-year 2022 results. Q4 revenues reached $42.9 million, a 6% increase from $40.3 million in Q4 2021, with operating income rising 12% to $8.8 million. Full-year revenues grew 11% to $183.5 million, while net income increased to $35 million from $33.1 million. The diluted earnings per share for 2022 rose to $19.56 from $18.18. The company noted a slight decline in gross profit margin due to rising costs. Despite challenges, Atrion remains debt-free and is investing in future growth, including a $41 million ERP system and facility expansions.
- Q4 2022 revenues increased 6% to $42.9 million.
- Operating income rose 12% in Q4 2022, reaching $8.8 million.
- Full-year 2022 revenues grew 11% to $183.5 million.
- Net income increased to $35 million for the full year.
- Earnings per share for full year 2022 rose 8% to $19.56.
- Company remains debt-free while investing in growth.
- Gross profit margin decreased to 41% in 2022 from 42% in 2021 due to rising costs.
ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022.
Revenues for the fourth quarter of 2022 totaled
Commenting on the results of the quarter and the full year compared to prior year periods, David Battat, President and CEO, stated, “We are very pleased with the results of the quarter when, despite supply disruptions, revenues were up
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Contact:
Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800
ATRION CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
Revenues | $ | 42,855 | $ | 40,293 | $ | 183,506 | $ | 165,009 | |||||||
Cost of goods sold | 24,681 | 22,917 | 107,602 | 95,637 | |||||||||||
Gross profit | 18,174 | 17,376 | 75,904 | 69,372 | |||||||||||
Operating expenses | 9,369 | 9,538 | 36,217 | 33,330 | |||||||||||
Operating income | 8,805 | 7,838 | 39,687 | 36,042 | |||||||||||
Interest and dividend income | 349 | 163 | 988 | 843 | |||||||||||
Other investment income (loss) | (366 | ) | 625 | (150 | ) | 1,477 | |||||||||
Other income | -- | -- | 92 | 67 | |||||||||||
Income before income taxes | 8,788 | 8,626 | 40,617 | 38,429 | |||||||||||
Income tax provision | (466 | ) | (499 | ) | (5,609 | ) | (5,374 | ) | |||||||
Net income | $ | 8,322 | $ | 8,127 | $ | 35,008 | $ | 33,055 | |||||||
Income per basic share | $ | 4.70 | $ | 4.51 | $ | 19.59 | $ | 18.22 | |||||||
Weighted average basic shares outstanding | 1,770 | 1,801 | 1,787 | 1,814 | |||||||||||
Income per diluted share | $ | 4.70 | $ | 4.50 | $ | 19.56 | $ | 18.18 | |||||||
Weighted average diluted shares outstanding | 1,771 | 1,806 | 1,790 | 1,818 |
ATRION CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)
Dec. 31, | Dec. 31, | ||||||
ASSETS | 2022 | 2021 | |||||
(Unaudited) | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 4,731 | $ | 32,264 | |||
Short-term investments | 21,152 | 29,059 | |||||
Total cash and short-term investments | 25,883 | 61,323 | |||||
Accounts receivable | 23,951 | 21,023 | |||||
Inventories | 65,793 | 50,778 | |||||
Prepaid expenses and other | 3,770 | 3,447 | |||||
Total current assets | 119,397 | 136,571 | |||||
Long-term investments | 8,669 | 19,423 | |||||
Property, plant and equipment, net | 123,754 | 97,972 | |||||
Other assets | 12,892 | 13,298 | |||||
$ | 264,712 | $ | 267,264 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities | 18,098 | 13,346 | |||||
Line of credit | -- | -- | |||||
Other non-current liabilities | 7,073 | 9,622 | |||||
Stockholders’ equity | 239,541 | 244,296 | |||||
$ | 264,712 | $ | 267,264 |
FAQ
What were Atrion's Q4 2022 earnings results?
How did Atrion's full-year 2022 performance compare to 2021?
What is the diluted earnings per share for Atrion for 2022?
Did Atrion face any challenges in 2022?